🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

🧬Chris Moxham - Transcripta Bio - Part 2 | From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"

🧬Chris Moxham - Transcripta Bio - Part 1 | From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science

🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy

🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There

🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen

🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition

🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science & Business

🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

🧬 eMalick Njie, Ph.D - Ecotone - Part 3 | Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies

🧬eMalick Njie, Ph.D - Ecotone - Part 2 | What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale

🧬eMalick Njie, Ph.D - Ecotone - Part 1 | Growing Up in the Gambia | The Unending Book of Neuroscience | Being a Professional Scientist | How to Lose Your MIT Recommendation Letter: 101

🧬Barbara Alcaraz Silva - J.P. Morgan - Part 4 | Barbara’s Pivot into Banking | The Power of Mentorship & Resilience | Seizing Unexpected Opportunities | The Challenges of Building a Career in Science & Finance

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 3 | From Academia to Entrepreneurship, Investing, & Advising | Co-Founding a Startup | Challenges of Early-Stage Company Building | Improve Your Investor Pitch & Connect with the Right People

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 2 | Mentorship & Research at the Beckman Laser Institute | An Entrepreneurial PhD Experience | Exploring Stem Cell Biology in London | Navigating Networking & Postdoc Opportunities

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 1 | Living the American Dream & Emigrating From Mexico | Soaking Up Experiences & Embracing Opportunities | Researching at the Harvard of Mexico | Presenting In Spanish at a National Conference

🧬 Derek Hennecke - Kincell Bio - Part 4 | Building & Scaling Xcelience | Buy-Side vs. Sell-Side of M&A | The Importance of Continuous Learning | Transition into Investing & Board Member Work

🧬 Derek Hennecke - Kincell Bio - Part 3 | Starting an Operations Role in Egypt | The Importance of Teamwork | Moving into Biologics & Overseeing GMP Operations | Buying a Business & Founding Xcelience